Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypercoagulable states

R L Nachman1, R Silverstein

  • 1Department of Medicine, New York Hospital-Cornell Medical Center, NY 10021.

Annals of Internal Medicine
|October 15, 1993
PubMed
Summary
This summary is machine-generated.

Hypercoagulable states, both inherited and acquired, increase thromboembolism risk. Deficiencies in endothelial anticoagulant functions cause primary hypercoagulability, while activated surfaces drive secondary forms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Americans with Disabilities Act: implications for managed care for persons with mental illness and addiction disorders.

Issue brief (George Washington University. Center for Health Services Research and Policy)·2002
Same author

Structural and functional characterization of the mouse fatty acid translocase promoter: activation during adipose differentiation.

The Biochemical journal·2001
Same author

The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities.

Transactions of the American Clinical and Climatological Association·2001
Same author

Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1.

The Journal of clinical investigation·2001
Same author

What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat.

American journal of respiratory cell and molecular biology·2000

Area of Science:

  • Hematology
  • Vascular Biology
  • Thrombosis Research

Background:

  • Hypercoagulable states are characterized by an elevated risk of thromboembolism.
  • These states can be inherited or acquired, stemming from complex pathophysiologic mechanisms.

Purpose of the Study:

  • To elucidate the pathophysiologic mechanisms of inherited and secondary hypercoagulable states.
  • To evaluate the frequency, natural history, diagnosis, and management of related clinical disorders.

Main Methods:

  • Literature review of hematology textbooks and computerized indexes.
  • Formulation of a hypothesis based on existing literature and experimental studies.

Main Results:

  • Inherited hypercoagulable states involve disordered endothelial thromboregulation (e.g., deficiencies in antithrombin III, protein C, protein S).

Related Experiment Videos

  • Acquired hypercoagulable states arise from endothelial activation, leading to a prothrombotic phenotype (e.g., antiphospholipid syndrome, cancer).
  • Conclusions:

    • Normal thromboregulation is primarily a function of the vessel wall.
    • Deficiencies in endothelial anticoagulant activities define primary hypercoagulable states.
    • Activated endothelial cells contribute to secondary or acquired hypercoagulability.